MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,337,292 | -71.4% | 30,700 | -76.3% | 0.01% | -75.0% |
| Q2 2023 | $4,683,747 | +452.5% | 129,636 | +468.6% | 0.04% | +400.0% |
| Q1 2023 | $847,666 | +128.1% | 22,799 | +178.0% | 0.01% | +166.7% |
| Q4 2022 | $371,542 | -77.3% | 8,200 | -65.0% | 0.00% | -78.6% |
| Q3 2022 | $1,636,000 | -23.9% | 23,427 | -26.8% | 0.01% | -33.3% |
| Q2 2022 | $2,149,000 | -10.4% | 32,001 | +95.7% | 0.02% | -4.5% |
| Q4 2021 | $2,398,000 | -27.6% | 16,350 | -12.7% | 0.02% | -35.3% |
| Q3 2021 | $3,313,000 | -31.9% | 18,727 | -37.8% | 0.03% | -34.6% |
| Q2 2021 | $4,866,000 | +1204.6% | 30,122 | +1680.3% | 0.05% | +940.0% |
| Q4 2020 | $373,000 | +25.6% | 1,692 | -5.3% | 0.01% | -16.7% |
| Q3 2020 | $297,000 | -76.7% | 1,786 | -84.0% | 0.01% | -64.7% |
| Q2 2020 | $1,274,000 | -0.5% | 11,158 | -33.0% | 0.02% | -79.0% |
| Q1 2020 | $1,280,000 | -64.7% | 16,655 | -40.8% | 0.08% | -8.0% |
| Q4 2019 | $3,627,000 | -62.8% | 28,137 | -77.5% | 0.09% | -69.2% |
| Q3 2019 | $9,739,000 | -57.1% | 125,000 | -43.3% | 0.29% | -64.4% |
| Q2 2019 | $22,702,000 | +92.1% | 220,400 | +36.7% | 0.80% | +95.9% |
| Q1 2019 | $11,817,000 | +206.5% | 161,200 | +77.3% | 0.41% | +177.0% |
| Q4 2018 | $3,856,000 | +50.2% | 90,900 | +66.8% | 0.15% | +29.8% |
| Q3 2018 | $2,567,000 | -41.6% | 54,500 | -38.8% | 0.11% | -52.1% |
| Q2 2018 | $4,393,000 | +649.7% | 89,100 | +177.5% | 0.24% | +395.8% |
| Q4 2017 | $586,000 | – | 32,113 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |